Neuropsychiatric disorders

Anxiety disorders and Attention-Deficit/Hyperactivity Disorder (ADHD) are among the most frequently diagnosed neuropsychiatric conditions worldwide. While many individuals respond well to conventional treatments, these pharmacological interventions often come with unwanted side effects and, in some cases, carry the potential for misuse or diversion.

Recent research has significantly advanced our understanding of the biological underpinnings and pharmacological management of both anxiety and ADHD. Ongoing studies continue to shed light on the pathophysiology, treatment strategies, and behavioral implications of these disorders, including self-harming behaviors.

 

    Related Conference of Neuropsychiatric disorders

    September 22-23, 2025

    6th Annual Congress on Psychiatry

    Paris, France
    October 27-28, 2025

    39th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    November 10-11, 2025

    5th Annual Psychiatrists and Psychologists Meet

    Vancouver, Canada
    November 10-11, 2025

    International Congress on Cognitive Psychotherapy

    Vancouver, Canada
    November 24-25, 2025

    5thAnnual Congress on Mental Health & Psychiatry

    Barcelona, Spain
    February 16-16, 2026

    43rd Global Psychiatry and Mental Health Conference

    Paris, France
    February 16-17, 2026

    6th Annual Congress on Mental Health

    Paris, France
    April 20-21, 2026

    33rd World Psychiatrists and Psychologists Meet

    Rome, Italy
    May 27-28, 2026

    8th European Autism Congress

    Paris, France

    Neuropsychiatric disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in